clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Achlorhydria D000126 1 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Angina Pectoris D000787 27 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Bacterial Infections D001424 21 associated lipids
Bacteriuria D001437 7 associated lipids
Barrett Esophagus D001471 3 associated lipids
Bartonella Infections D001474 3 associated lipids
Body Weight D001835 333 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bradycardia D001919 13 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchitis D001991 6 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Chlamydia Infections D002690 7 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Colitis D003092 69 associated lipids
Confusion D003221 4 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Cross Infection D003428 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cysts D003560 4 associated lipids
Dermatitis, Exfoliative D003873 10 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatomycoses D003881 17 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diarrhea D003967 32 associated lipids
Diphtheria D004165 2 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenitis D004382 4 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Dyspepsia D004415 5 associated lipids
Dyspnea D004417 10 associated lipids
Ecchymosis D004438 3 associated lipids
Empyema D004653 3 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Acute Disseminated D004673 1 associated lipids
Endometriosis D004715 29 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ergotism D004881 4 associated lipids
Erythema Nodosum D004893 5 associated lipids
Esophagitis, Peptic D004942 4 associated lipids
Euthyroid Sick Syndromes D005067 1 associated lipids
Exanthema D005076 11 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Fistula D005402 8 associated lipids
Foot Diseases D005534 4 associated lipids
Fractures, Open D005597 3 associated lipids
Fusobacterium Infections D005674 3 associated lipids
Gastritis D005756 27 associated lipids
Gastritis, Atrophic D005757 4 associated lipids
Gastritis, Hypertrophic D005758 1 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Giardiasis D005873 3 associated lipids
Glossitis, Benign Migratory D005929 1 associated lipids
Granuloma, Plasma Cell D006104 1 associated lipids
Hand Dermatoses D006229 5 associated lipids
Hearing Disorders D006311 10 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Heart Failure D006333 36 associated lipids
Hemolysis D006461 131 associated lipids
Hemophilia A D006467 10 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hernia, Hiatal D006551 3 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypoproteinemia D007019 1 associated lipids
Immunoproliferative Small Intestinal Disease D007161 2 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Influenza, Human D007251 11 associated lipids
Insulin Resistance D007333 99 associated lipids
Iris Diseases D007499 2 associated lipids
Iritis D007500 2 associated lipids
Ischemia D007511 18 associated lipids
Keratoconjunctivitis D007637 3 associated lipids
Klebsiella Infections D007710 7 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Legionnaires' Disease D007877 4 associated lipids
Leishmaniasis, Visceral D007898 13 associated lipids
Leprosy D007918 8 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Grunden JW and Fisher KA Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. 1997 Jul-Aug Ann Pharmacother pmid:9220046
Wintermeyer SM et al. Dirithromycin: a new macrolide. 1996 Ann Pharmacother pmid:8893122
González Carro P et al. Acute pancreatitis and modified-release clarithromycin. 2004 Ann Pharmacother pmid:14755067
Saint-Blancard P et al. [Cutaneous nodular infection with hemopathy]. 2000 Ann Pathol pmid:11015652
Arakawa R et al. No inhibitory effect on P-glycoprotein function at blood-brain barrier by clinical dose of clarithromycin: a human PET study with [¹¹C]verapamil. 2010 Ann Nucl Med pmid:20069466
Granier H et al. [Mycobacterium chelonei arthritis in an immunosuppressed patient. Efficacy of the treatment with clarithromycin]. 1993 Ann Med Interne (Paris) pmid:8141516
Shojaei H et al. Chronic pulmonary disease due to Mycobacterium monacense infection: the first case from Iran. 2012 Ann Lab Med pmid:22259785
Choi SJ et al. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. 2012 Ann Lab Med pmid:22563554
Lee SH et al. The drug resistance profile of Mycobacterium abscessus group strains from Korea. 2014 Ann Lab Med pmid:24422193
Hong SK et al. First case of Mycobacterium longobardum infection. 2013 Ann Lab Med pmid:24003427
Karne SS et al. Mycobacterium avium-intracellulare brain abscess in HIV-positive patient. 2012 Ann Indian Acad Neurol pmid:22412276
Leiba A et al. An unusual case of hypoglycemia in a diabetic patient. 2004 Ann Emerg Med pmid:15460592
Kundu S et al. Clarithromycin-induced ventricular tachycardia. 1997 Ann Emerg Med pmid:9326871
Wastiaux H et al. [Bursitis due to Mycobacterium intracellulare in an immunocompetent patient]. 2008 Jun-Jul Ann Dermatol Venereol pmid:18598800
Radouane N et al. [Generalized chromomycosis caused by Phialophora verrucosa]. 2013 Ann Dermatol Venereol pmid:23466152
Huynh VA et al. [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis]. 2016 Ann Dermatol Venereol pmid:27080820
Domergue Thân Trong E et al. [Mycobacterium kansasii skin infection at insulin injection sites]. 2001 Ann Dermatol Venereol pmid:11319391
Bordet AL et al. [Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin]. 1997 Ann Dermatol Venereol pmid:9686059
Régnier S et al. [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases]. 2008 Aug-Sep Ann Dermatol Venereol pmid:18789296
Sambourg E et al. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana]. Ann Dermatol Venereol pmid:24951139
Dupin N [Paradoxal cultures]. Ann Dermatol Venereol pmid:24951138
Kwon YH et al. A Case of Skin and Soft Tissue Infection Caused by Mycobacterium abscessus. 2009 Ann Dermatol pmid:20548866
Cho AY et al. Identification of Cutaneous Mycobacterium massiliense Infections Associated with Repeated Surgical Procedures. 2010 Ann Dermatol pmid:20548899
Flisch CW et al. [A case of arthritis of the wrist caused by Mycobacterium marinum. Review of the literature]. 1996 Ann Chir Main Memb Super pmid:9026056
Tran TT and Quandalle P [Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication]. 2002 Ann Chir pmid:11833303
Tran TT and Quandalle P [Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori]. 2006 Ann Chir pmid:16716245
Miwa S et al. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. 2014 Ann Am Thorac Soc pmid:24298907
Morimoto K et al. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. 2017 Ann Am Thorac Soc pmid:27788025
Morimoto K et al. Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. 2016 Ann Am Thorac Soc pmid:27513168
Pathak V et al. Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia. 2014 Ann Am Thorac Soc pmid:24460438
Lee G et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. 2013 Ann Am Thorac Soc pmid:23952847
Stricker RB et al. Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. 2002 Ann Agric Environ Med pmid:12088407
Aguilar JA et al. Decoupling two-dimensional NMR spectroscopy in both dimensions: pure shift NOESY and COSY. 2012 Angew. Chem. Int. Ed. Engl. pmid:22588724
Eremenko AA et al. [Effect of clarithromycin on the systemic inflammatory response syndrome severity in patients after myocardial revascularization surgery]. 2012 May-Jun Anesteziol Reanimatol pmid:22993930
Spisso BF et al. Simultaneous determination of polyether ionophores, macrolides and lincosamides in hen eggs by liquid chromatography-electrospray ionization tandem mass spectrometry using a simple solvent extraction. 2010 Anal. Chim. Acta pmid:21056719
Xing J et al. The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans. 2015 Anal. Chim. Acta pmid:26515003
Galvidis I et al. Group determination of 14-membered macrolide antibiotics and azithromycin using antibodies against common epitopes. 2015 Anal. Biochem. pmid:25256165
Dong SY et al. Electrochemical studies of the interaction of clarithromycin with bovine serum albumin. 2008 Anal Sci pmid:18781017
Marina M et al. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria. 2009 Anaerobe pmid:19292999
Boyanova L et al. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. 2004 Anaerobe pmid:16701526
Senhorinho GN et al. Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. 2012 Anaerobe pmid:22609780
Utük O et al. [The effects of clarithromycin treatment on cardiac events in acute coronary syndrome patients]. 2004 Anadolu Kardiyol Derg pmid:15355822
Giménez Sánchez F et al. [Clinicoepidemiological characteristics of community-acquired pneumonia in children aged less than 6 years old]. 2007 An Pediatr (Barc) pmid:17583619
Baquero-Artigao F [Pediatric infections caused by nontuberculous mycobacteria]. 2005 An Pediatr (Barc) pmid:15871828
Alcalá Minagorre PJ et al. [Rickettsia slovaca infection alter a tick bite]. 2006 An Pediatr (Barc) pmid:17020735
Garcés-Sánchez M et al. [Epidemiology and burden of acute otitis media in Valencia (Spain)]. 2004 An Pediatr (Barc) pmid:14757015
Sanz Santaeufemia FJ et al. [Usefulness of chemotherapy associated with surgery in the management of nontuberculous mycobacterial adenitis]. 2005 An Pediatr (Barc) pmid:15737291
Bujanda L et al. [Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days]. 2001 An Med Interna pmid:11534420
Gómez Cubillos C et al. [Can macrolide treatment delay the diagnosis of tuberculosis?]. 1999 An Med Interna pmid:10481348
Díaz García MJ et al. [EKG changes in a patient with respiratory infection]. 2005 An Med Interna pmid:16302306
Alegre Herrera S et al. [Clarithromycin-carbamazepine interaction: neurological symptoms and hyponatremia]. 1998 An Med Interna pmid:9522506
Lage R et al. Mycobacterium chelonae cutaneous infection in a patient with mixed connective tissue disease. An Bras Dermatol pmid:25672306
Moreira C et al. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin. An Bras Dermatol pmid:28954125
Heifets LB et al. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. 1992 Am. Rev. Respir. Dis. pmid:1532486
Ruf B et al. Acquired resistance of MAI to clarithromycin. 1992 Am. Rev. Respir. Dis. pmid:1533999
Dautzenberg B et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. 1991 Am. Rev. Respir. Dis. pmid:1832527
Womble AY et al. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals. 2006 Am. J. Vet. Res. pmid:17014316
Marini RP et al. Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. 1999 Am. J. Vet. Res. pmid:10791942
de Zeeuw J et al. Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection. 2013 Am. J. Trop. Med. Hyg. pmid:23836576
Semret M et al. Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. 1999 Am. J. Trop. Med. Hyg. pmid:10586895
Morovic M Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only? 2005 Am. J. Trop. Med. Hyg. pmid:16282309
Lee N et al. Risk factors associated with life-threatening rickettsial infections. 2008 Am. J. Trop. Med. Hyg. pmid:18541779
Fajardo TT et al. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. 2006 Am. J. Trop. Med. Hyg. pmid:16525107
Miftahussurur M et al. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic. 2017 Am. J. Trop. Med. Hyg. pmid:28193745
Stout JE and Floto RA Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others. 2012 Am. J. Respir. Crit. Care Med. pmid:23118083
Bates JH Mycobacterium avium disease: progress at last. 1996 Am. J. Respir. Crit. Care Med. pmid:8665029
Wallace RJ et al. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. 1996 Am. J. Respir. Crit. Care Med. pmid:8665032
Frothingham R Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease. 1996 Am. J. Respir. Crit. Care Med. pmid:8665069
Nakanishi Y et al. Clarithromycin prevents smoke-induced emphysema in mice. 2009 Am. J. Respir. Crit. Care Med. pmid:19060231
Rubin BK et al. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. 1997 Am. J. Respir. Crit. Care Med. pmid:9196110
Jeong BH et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. 2015 Am. J. Respir. Crit. Care Med. pmid:25393520
Koh WJ et al. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. 2012 Am. J. Respir. Crit. Care Med. pmid:22878282
Griffith DE et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. 2006 Am. J. Respir. Crit. Care Med. pmid:16858014
Pasipanodya JG and Gumbo T Drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions. 2013 Am. J. Respir. Crit. Care Med. pmid:23457368
Tanaka E et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. 1999 Am. J. Respir. Crit. Care Med. pmid:10471610
Shimizu T et al. In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. 2003 Am. J. Respir. Crit. Care Med. pmid:12829454
Wallace RJ et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. 1994 Am. J. Respir. Crit. Care Med. pmid:8173775
Koh WJ et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. 2011 Am. J. Respir. Crit. Care Med. pmid:20833823
Yanagihara K et al. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. 1997 Am. J. Respir. Crit. Care Med. pmid:9001333
Jeon K et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. 2009 Am. J. Respir. Crit. Care Med. pmid:19661243
Lam PK et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. 2006 Am. J. Respir. Crit. Care Med. pmid:16514112
Barker PM et al. Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. 2005 Am. J. Respir. Crit. Care Med. pmid:15657462
Azuma M et al. Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice. 2007 Am. J. Respir. Crit. Care Med. pmid:17717205
Simpson JL et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. 2008 Am. J. Respir. Crit. Care Med. pmid:17947611
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
Schluger NW Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? 2012 Am. J. Respir. Crit. Care Med. pmid:23071188
Koh WJ et al. Reply: drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions. 2013 Am. J. Respir. Crit. Care Med. pmid:23577353
van Ingen J et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. 2012 Am. J. Respir. Crit. Care Med. pmid:22744719
Tanabe T et al. Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21642590
Abe S et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. 2000 Am. J. Respir. Cell Mol. Biol. pmid:10615065
Oberley-Deegan RE et al. The antioxidant mimetic, MnTE-2-PyP, reduces intracellular growth of Mycobacterium abscessus. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19097985
Yamasawa H et al. Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release. 2004 Am. J. Respir. Cell Mol. Biol. pmid:14551160
Kaneko Y et al. Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12818892
Shinkai M et al. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. 2006 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:16085674
Chmura K et al. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. 2008 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:18487355
Feldman M et al. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. 1999 Am. J. Physiol. pmid:10600812
Kuehne JJ et al. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. 2004 Am. J. Ophthalmol. pmid:15488779
Helm CJ et al. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. 1993 Am. J. Ophthalmol. pmid:8250072
Chandra NS et al. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. 2001 Am. J. Ophthalmol. pmid:11730644
Witt A et al. Placental passage of clarithromycin surpasses other macrolide antibiotics. 2003 Am. J. Obstet. Gynecol. pmid:12634663